
- Volume 0 0
AMNEAL AND INDOCO PARTNER TO MAKE GENERIC OPHTHALMICS
A new generic-industryjoint venturelinking New Jersey?based Amneal Pharmaceuticalsand India?sIndoco Remedieswill result in themarketing of at least10 generic ophthalmic products in the United States.
Amneal?s role in the partnership will be to prepare andfile abbreviated new drug applications for FDA approvaland to exclusively market these products throughout theUS pharmaceutical market. Indoco will be responsible formanufacturing the generics. Spokesmen for the 2 companiessaid that Indoco and Amneal have already begun toidentify several more ophthalmic products to pursue, aswell as other therapeutic categories and dosage forms.
Articles in this issue
almost 18 years ago
Understanding Cholesterol: Do You Know Your Numbers?almost 18 years ago
Case Studiesalmost 18 years ago
can you READ these Rxs?almost 18 years ago
DIABETES WATCHalmost 18 years ago
HYPERTENSION WATCHalmost 18 years ago
compounding HOTLINEalmost 18 years ago
feature: Telepharmacy Improves Safety in Chemotherapy Preparationalmost 18 years ago
feature: onePAC Innovates Drug Dispensing on Long-term Carealmost 18 years ago
pharmacy TECHNOLOGY productsalmost 18 years ago
Stopping Medications Can Cause Adverse EffectsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.